Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective binding to enzyme active sites, enhancing drug efficacy. Also employed in catalysis research due to the phosphinyl group, supporting the design of novel asymmetric reactions. Shows potential in creating fluorinated analogs for improved metabolic stability in drug candidates.